Waldemar Priebe - Publications

Affiliations: 
Experimental Therapeutics University of Texas MD Anderson Cancer Center, Houston, TX, United States 
Area:
drug design
Website:
https://faculty.mdanderson.org/profiles/waldemar_priebe.html

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, et al. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. Journal of Translational Medicine. 14: 46. PMID 26861698 DOI: 10.1186/s12967-016-0803-2  1
2015 Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, et al. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem Cells (Dayton, Ohio). 33: 2400-15. PMID 25966666 DOI: 10.1002/stem.2053  1
2015 Mansilla S, Vizcaíno C, Rodríguez-Sánchez MA, Priebe W, Portugal J. Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells. Journal of Cellular and Molecular Medicine. 19: 786-98. PMID 25689150 DOI: 10.1111/jcmm.12402  1
2014 Kong LY, Wei J, Haider AS, Liebelt BD, Ling X, Conrad CA, Fuller GN, Levine NB, Priebe W, Sawaya R, Heimberger AB. Therapeutic targets in subependymoma. Journal of Neuroimmunology. 277: 168-75. PMID 25465288 DOI: 10.1016/j.jneuroim.2014.10.008  1
2014 Judd LM, Menheniott TR, Ling H, Jackson CB, Howlett M, Kalantzis A, Priebe W, Giraud AS. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. Plos One. 9: e95993. PMID 24804649 DOI: 10.1371/journal.pone.0095993  1
2014 Emmett MR, Kroes RA, Moskal JR, Conrad CA, Priebe W, Laezza F, Meyer-Baese A, Nilsson CL. Integrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 5-23. PMID 23800968 DOI: 10.1038/npp.2013.156  1
2013 Mielecki M, Krawiec K, Kiburu I, Grzelak K, Zagórski W, Kierdaszuk B, Kowa K, Fokt I, Szymanski S, Świerk P, Szeja W, Priebe W, Lesyng B, Laronde-Leblanc N. Development of novel molecular probes of the Rio1 atypical protein kinase Biochimica Et Biophysica Acta - Proteins and Proteomics. 1834: 1292-1301. PMID 23523885 DOI: 10.1016/j.bbapap.2013.03.012  1
2012 Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro-Oncology. 14: 1136-45. PMID 22753228 DOI: 10.1093/neuonc/nos139  1
2012 Swiatek-Machado K, Mieczkowski J, Ellert-Miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska B. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells. Cancer Biology & Therapy. 13: 657-70. PMID 22555804 DOI: 10.4161/cbt.20083  1
2012 Sai K, Wang S, Balasubramaniyan V, Conrad C, Lang FF, Aldape K, Szymanski S, Fokt I, Dasgupta A, Madden T, Guan S, Chen Z, Alfred Yung WK, Priebe W, Colman H. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. Journal of Neuro-Oncology. 107: 487-501. PMID 22249692 DOI: 10.1007/s11060-011-0786-z  1
2011 Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, ... ... Priebe W, et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell. 20: 384-99. PMID 21907928 DOI: 10.1016/j.ccr.2011.08.013  1
2011 Kapuria V, Levitzki A, Bornmann WG, Maxwell D, Priebe W, Sorenson RJ, Showalter HD, Talpaz M, Donato NJ. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination Cellular Signalling. 23: 2076-2085. PMID 21855629 DOI: 10.1016/j.cellsig.2011.08.002  1
2011 Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 117: 2926-38. PMID 21692052 DOI: 10.1002/cncr.25868  1
2010 Pham LV, Tamayo AT, Li C, Bornmann W, Priebe W, Ford RJ. Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications. Molecular Cancer Therapeutics. 9: 2026-36. PMID 20606045 DOI: 10.1158/1535-7163.MCT-10-0238  1
2010 Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2550-61. PMID 20388845 DOI: 10.1158/1078-0432.CCR-10-0279  1
2010 He H, Nilsson CL, Emmett MR, Marshall AG, Kroes RA, Moskal JR, Ji Y, Colman H, Priebe W, Lang FF, Conrad CA. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. Journal of Proteome Research. 9: 2098-108. PMID 20199106 DOI: 10.1021/pr900793a  1
2010 Nilsson CL, Dillon R, Devakumar A, Shi SD, Greig M, Rogers JC, Krastins B, Rosenblatt M, Kilmer G, Major M, Kaboord BJ, Sarracino D, Rezai T, Prakash A, Lopez M, ... ... Priebe W, et al. Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. Journal of Proteome Research. 9: 430-43. PMID 19899826 DOI: 10.1021/pr9007927  1
2009 Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya R. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clinical Neurosurgery. 56: 98-106. PMID 20214040  1
2008 Kong LY, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W, Fuller GN, Fokt I, Grimm EA, Schmittling RJ, Archer GE, Sampson JH, Priebe W, Heimberger AB. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5759-68. PMID 18794085 DOI: 10.1158/1078-0432.CCR-08-0377  1
2007 Gruber BM, Anuszewska EL, Bubko I, Goździk A, Fokt I, Priebe W. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells. Archivum Immunologiae Et Therapiae Experimentalis. 55: 193-8. PMID 17557149 DOI: 10.1007/s00005-007-0018-6  1
2007 Bidwell GL, Davis AN, Fokt I, Priebe W, Raucher D. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Investigational New Drugs. 25: 313-26. PMID 17483874 DOI: 10.1007/s10637-007-9053-8  1
2007 Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Research. 67: 684-94. PMID 17234779 DOI: 10.1158/0008-5472.CAN-06-3166  1
2007 Bidwell GL, Fokt I, Priebe W, Raucher D. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochemical Pharmacology. 73: 620-31. PMID 17161827 DOI: 10.1016/j.bcp.2006.10.028  1
2007 Brooks TA, O'Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, Bernacki RJ, Priebe W, Baer MR. The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells Investigational New Drugs. 25: 115-122. PMID 17072745 DOI: 10.1007/s10637-006-9018-3  1
2006 Gruber BM, Anuszewska EL, Roman I, Goździk A, Priebe W, Fokt I. Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells. Acta Poloniae Pharmaceutica. 63: 15-8. PMID 17515324  1
2006 Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe W. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells". Cancer Chemotherapy and Pharmacology. 58: 725-34. PMID 16555088 DOI: 10.1007/s00280-006-0207-8  1
2005 Portugal J, Cashman DJ, Trent JO, Ferrer-Miralles N, Przewloka T, Fokt I, Priebe W, Chaires JB. A new bisintercalating anthracycline with picomolar DNA binding affinity Journal of Medicinal Chemistry. 48: 8209-8219. PMID 16366602 DOI: 10.1021/jm050902g  1
2005 Gruber BM, Anuszewska EL, Bubko I, Gozdzik A, Priebe W, Fokt I. Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells. Anticancer Research. 25: 2193-8. PMID 16158963  1
2005 Gruber BM, Anuszewska EL, Bubko I, Kasprzycka-Guttman T, Misiewicz I, Skupińska K, Priebe W, Fokt I. Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines. Acta Poloniae Pharmaceutica. 62: 17-23. PMID 16022489  1
2005 Maher JC, Savaraj N, Priebe W, Liu H, Lampidis TJ. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression. Pancreas. 30: e34-9. PMID 15714127  1
2004 Inge TH, Harris NL, Wu J, Azizkhan RG, Priebe W. WP744 is a novel anthracycline with enhanced activity against neuroblastoma. The Journal of Surgical Research. 121: 187-96. PMID 15501458 DOI: 10.1016/j.jss.2004.03.027  1
2004 Fox KR, Webster R, Phelps RJ, Fokt I, Priebe W. Sequence selective binding of bis-daunorubicin WP631 to DNA. European Journal of Biochemistry / Febs. 271: 3556-66. PMID 15317591 DOI: 10.1111/j.0014-2956.2004.04292.x  1
2004 Gruber BM, Anuszewska EL, Priebe W. The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells. Folia Histochemica Et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 42: 127-30. PMID 15253137  1
2002 Inge TH, Casson LK, Priebe W, Trent JO, Georgeson KE, Miller DM, Bates PJ. Importance of Sp1 consensus motifs in the MYCN promoter. Surgery. 132: 232-8. PMID 12219017 DOI: 10.1067/msy.2002.125387  1
1997 Perez-Soler R, Neamati N, Zou Y, Schneider E, Doyle LA, Andreeff M, Priebe W, Ling YH. Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide. International Journal of Cancer. 71: 35-41. PMID 9096663 DOI: 10.1002/(SICI)1097-0215(19970328)71:1<35::AID-IJC8>3.0.CO;2-4  1
1993 Horton D, Issa M, Priebe W, Sznaidman ML. Synthesis of 3-deoxyaldulosonic acid esters by one-carbon chain extension of glycal-derived lactone precursors. Carbohydrate Research. 246: 105-18. PMID 8370034  1
1993 Horton D, Priebe W, Sznaidman ML, Varela O. Synthesis and antitumor activity of anthracycline disaccharide glycosides containing daunosamine Journal of Antibiotics. 46: 1720-1730. PMID 8270495  1
1992 Priebe W, Neamati N, Perez-soler R. 3'-Hydroxyesorubicin halogenated at C-2'. The Journal of Antibiotics. 45: 386-93. PMID 1577666  1
1990 Priebe W, Neamati N, Perez-Soler R. 3'-Hydroxyesorubicin. Synthesis and antitumor activity. The Journal of Antibiotics. 43: 838-46. PMID 2387778  1
1990 Horton D, Priebe W, Sznaidman M. Iodoalkoxylation of 1,5-anhydro-2-deoxy-hex-1-enitols (glycals). Carbohydrate Research. 205: 71-86. PMID 2276153  1
1990 Horton D, Priebe W, Carter JP, Filppi J, Wolgemuth RL. 4-Demethoxy-3'-N-trifluoroacetyldoxorubicin. Synthesis and solid tumor activity. Drug Design and Delivery. 6: 123-9. PMID 2080980  1
1989 Horton D, Priebe W, Sznaidman M. A new approach to 2-deoxyglycosides permitting access to anthracycline glycosides specifically labeled at the 2'-position. Carbohydrate Research. 187: 149-53. PMID 2752389  1
1989 Horton D, Priebe W, Sznaidman M. Preparation of 4-O-acetyl-1,5-anhydro-2,3,6-trideoxy-3-trifluoroacetamido-L- lyxo-hex-1-enitol, a key intermediate in synthesis of daunosamine glycosides. Carbohydrate Research. 187: 145-8. PMID 2752388  1
1988 Horton D, Priebe W, Sznaidman M. Preparative procedures for conversion of daunorubicin into doxorubicin (Adriamycin) and 14-O-acetyldoxorubicin by way of 14-bromodaunorubicin. Carbohydrate Research. 184: 231-5. PMID 3242811  1
1985 Bhaté P, Horton D, Priebe W. Allylic rearrangement of 6-deoxyglycals having practical utility. Carbohydrate Research. 144: 331-7. PMID 4092212  1
1985 Horton D, Priebe W, Varela O. Selective silylation of 6-deoxyglycals Carbohydrate Research. 144: 325-330. PMID 4092211 DOI: 10.1016/S0008-6215(00)90680-3  1
1985 Horton D, Priebe W, Varela O. Selective acylation of 6-deoxyglycals Carbohydrate Research. 144: 317-324. PMID 4092210 DOI: 10.1016/S0008-6215(00)90679-7  1
1985 Horton D, Priebe W, Varela O. Synthesis and antitumor activity of 2′-bromo- and 2′-chloro-3′-acetoxy-3′-deaminodaunorubicin analogs Carbohydrate Research. 144: 305-315. PMID 4092209 DOI: 10.1016/S0008-6215(00)90678-5  1
1985 Cheung TM, Horton D, Priebe W, Turner WR, Weckerle W. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin. The Journal of Antibiotics. 38: 683-6. PMID 4019314  1
1985 Horton D, Priebe W. Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2'-halo daunorubicin analogs. Carbohydrate Research. 136: 391-6. PMID 4005892  1
1984 Horton D, Priebe W, Varela O. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity Journal of Antibiotics. 37: 1635-1641. PMID 6549317  1
1984 Horton D, Priebe W, Varela O. Synthesis and antitumor activity of 3'-deamino-3'-hydroxydoxorubicin. A facile procedure for the preparation of doxorubicin analogs Journal of Antibiotics. 37: 853-858. PMID 6548219  1
1983 Horton D, Priebe W. 14-esters of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone: synthesis and antitumor activity. The Journal of Antibiotics. 36: 1211-5. PMID 6630080  1
1981 Horton D, Priebe W. New adriamycin analogs. Synthesis and antitumor activity of 14-substituted 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)daunomycinones. The Journal of Antibiotics. 34: 1019-25. PMID 7319917  1
1981 Horton D, Priebe W, Turner WR. Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone. Carbohydrate Research. 94: 11-25. PMID 7260960  1
Show low-probability matches.